• Wed, May 15, 2013
  • Thu, May 16, 2013
  • Fri, May 17, 2013
  • Mon, May 20, 2013
  • Tue, May 21, 2013
  • Tue, May 14, 2013

David Amsellem Maintained (SUPN) at Buy with Decreased Target to $13 on, May 14th, 2013

David Amsellem of Piper Sandler, Maintained "Supernus Pharmaceuticals, Inc." (SUPN) at Buy with Decreased Target from $14 to $13 on, May 14th, 2013.

David has made no other calls on SUPN in the last 4 months.



There is 1 other peer that has a rating on SUPN. Out of the 1 peers that are also analyzing SUPN, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • David Steinberg of "Jefferies" Initiated at Strong Buy and Held Target at $13 on, Tuesday, March 5th, 2013